Posted in | eBooks

How to solve the hidden bottleneck in lipid nanoparticle development

Outdated offline methods are slowing you down. They compromise speed, consistency, and regulatory confidence. It’s time for a continuous solution.

Download the full eBook now to learn more!

This new eBook from Inprocess LSP shows how to overcome these bottlenecks with real-time, continuous particle size analysis. It offers practical guidance on enhancing process control, accelerating development, and achieving seamless scale-up.

Lipid nanoparticles (LNPs) are transforming drug delivery, powering innovations from mRNA vaccines to gene therapies. Yet, maintaining precise size control, which is essential for stability, efficacy, and regulatory approval, remains a major challenge. Traditional offline analysis often leads to delays, inconsistencies, and a lack of real-time visibility into production.

In today’s highly regulated and competitive landscape, success depends on rapid development, cost efficiency, and reliable tech transfer. With its flexible, modular design, the NanoFlowSizer is built to support every stage of development, from early R&D through to scale-up and full-scale manufacturing.

As the only real-time, “any configuration” solution of its kind, the NanoFlowSizer delivers the most accurate measurements, even in complex and diverse matrices.

In this eBook, you’ll learn how to:

  • Save time and effort (PAT): Access instant process insights with real-time data
  • Scale with confidence: Flexible modular configurations for volumes ranging from small-scale R&D to full manufacturing
  • Gain deeper process understanding: Leverage unique SR-DLS technology for richer, more detailed insights
  • Ensure reliable results: Create a direct process feedback loop for stronger control and consistency

How to solve the hidden bottleneck in lipid nanoparticle development

Image Credit: InProcess-LSP

Download the eBook today!

About InProcess-LSP

InProcess-LSP, headquartered in Oss at Pivot Park, is a rapidly growing, innovative company founded in 2014. Backed by a team of in-house experts—comprising physicists, chemists, and software engineers—InProcess-LSP is at the forefront of nanotechnology solutions. The company’s leading product, the NanoFlowSizer, is a cutting-edge instrument designed to deliver inline, real-time measurements of nanoparticles in solution, making it indispensable across various industries.

Utilizing Spatially Resolved Dynamic Light Scattering (SR-DLS) technology, the NanoFlowSizer enables accurate characterization of nanoparticles in flowing liquids, providing critical data such as hydrodynamic diameter, polydispersity index (PDI), and D90 within seconds.

This state-of-the-art instrument empowers both scientists and industries by offering a robust solution for analyzing nanoparticle properties, paving the way for breakthroughs in product development, improved formulations, and pioneering applications.

Innovators in Process Analytical Technology and nanoparticle characterization.

With their strong background in process analytics as well as many years of academic and industrial experience InProcess offer a highly skilled and experienced team of scientists and process specialists addressing the needs of your PAT and nanotechnology challenges.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.